First Trust NYSE Arca Biotechnology Index Fund FBT
256.90 USD -5.90 (-2.24%)
As ofNov 20, 2026, 3:59 PM EST
256.75 Day range 263.75
189.47 52-week range 283.21
- YTD
- +24.39%
- 1 year
- +27.28%
First Trust NYSE Arca Biotechnology Index Fund
- Issuer
- First Trust
- Asset class
- Sector Equity
- Expense ratio
- 0.55%
- Assets under management
- $3.03B
- NAV
- 271.49
- Holdings
- 30
- Inception
- 2006-06-19
- Top 10 weight
- 39.24%
Top holdings
- GMAB Genmab A/S (ADR) 4.88%
- ADMA ADMA Biologics, Inc. 4.00%
- REGN Regeneron Pharmaceuticals, Inc. 3.99%
- EXEL Exelixis, Inc. 3.88%
- NBIX Neurocrine Biosciences, Inc. 3.84%
- ONC BeOne Medicines Ltd. (ADR) 3.81%
- ARGX argenx SE (ADR) 3.78%
- TGTX TG Therapeutics, Inc. 3.71%
- ALKS Alkermes Plc 3.68%
- BRKR Bruker Corporation 3.66%
- BIIB Biogen Inc. 3.66%
- AMGN Amgen Inc. 3.63%
- GILD Gilead Sciences, Inc. 3.63%
- INCY Incyte Corporation 3.50%
- VRTX Vertex Pharmaceuticals Incorporated 3.50%
- NEO NeoGenomics, Inc. 3.49%
- UTHR United Therapeutics Corporation 3.44%
- BMRN BioMarin Pharmaceutical Inc. 3.38%
- RGEN Repligen Corporation 3.33%
- TECH Bio-Techne Corporation 3.26%
- TARS Tarsus Pharmaceuticals, Inc. 3.14%
- HALO Halozyme Therapeutics, Inc. 3.02%
- MDGL Madrigal Pharmaceuticals, Inc. 2.97%
- BNTX BioNTech SE (ADR) 2.92%
- NTRA Natera, Inc. 2.59%
Sector weights
- Healthcare 100.00%
Country weights
- United States 95.24%
- Denmark 4.76%
Updated 2026-11-11
Held by funds
2 US ETFs and mutual funds hold FBT · largest positions
